Updated on 14.03.2026 @ 6:08 PM
Neochem Bio Solutions Limited is launching its Initial Public Offering (IPO) on the NSE EMERGE platform. Investors who want to track more SME and mainboard listings can refer to our IPO Hub page.
It is a specialty chemicals company with over four decades of experience.
The subscription status for this public issue will open on December 2, 2025, and close on December 4, 2025.
The company aims to raise up to ₹44.97 crores through a 100% fresh issue of shares.
The price band has been fixed at ₹93 to ₹98 per share, with a minimum lot size of 1,200 shares.
Neochem Bio Solutions has demonstrated robust financial growth and improving profitability, but investors must be mindful of its sector and geographic concentration risks.
In this article, you will find Neochem Bio Solutions IPO GMP today, subscription status, allotment date, price band, and a detailed, unbiased review to help you make an informed decision.
Briefs of Neochem Bio Solutions IPO Details
- Price Band: ₹93 to ₹98 per share
- IPO Open / Close Dates: December 2, 2025 – December 4, 2025
- Lot Size: 1,200 Shares
- Issue Size: 45,88,800 shares (aggregating up to ₹44.97 Crores)
- Fresh Issue / OFS: 100% Fresh Issue
- Registrar: MUFG Intime India Pvt.Ltd.
- Listing Exchange: NSE SME
You can get more details about how to check allotment status at MUFG Intime at our details MUFG Intime detailed guide which has all the important information every investor needs who apply for the issue where MUFG is registrar.
What is The Neochem Bio Solutions IPO GMP Today?
You can check the grey market premium of this and other important IPOs at our GMP hub page.
Listing Updates
| Type | Issue Price | Open | Gain/loss |
| Lisiting | 98 | 108 | 10.2 |
Source: NSE India
What Are The Neochem Bio Solutions IPO Dates & Allotment Schedule?
- IPO Open & Close Date: December 2, 2025 – December 4, 2025
- Basis of Allotment Date: December 5, 2025
- Refund Initiation Date: December 8, 2025
- Credit of Shares: December 8, 2025
- Listing Date: December 9, 2025
What Are The Objectives of Neochem Bio Solutions IPO?
The company intends to utilise the net proceeds from the public offering primarily to strengthen its financial position and support growth:
- Funding Working Capital Requirements (₹23.90 Crores): A significant portion of the proceeds will be used to manage the long-term working capital needs, crucial for maintaining inventory and extending credit to customers.
- Repayment of Borrowings (₹10.00 Crores): To reduce a portion of its outstanding debt, which will lower interest costs and improve financial leverage.
- General Corporate Purposes: The balance amount will be used for other strategic requirements.
How is The Financial Performance of Neochem Bio Solutions?
The following table summarizes the company's financial performance based on restated consolidated data.
(Amounts in ₹ Crores)
| Particulars | Period Ended 30 Sep 2025 (6 Months) | Year Ended 31 Mar 2025 | Year Ended 31 Mar 2024 | Year Ended 31 Mar 2023 |
Total Income | 47.18 | 86.15 | 62.01 | 48.79 |
Profit After Tax (PAT) | 5.48 | 7.75 | 1.80 | 1.07 |
EBITDA | 8.59 | 13.11 | 5.99 | 4.23 |
Net Worth | 32.24 | 19.75 | 12.00 | 8.05 |
Total Borrowing | 38.54 | 35.62 | 33.32 | 26.24 |
Assets | 96.49 | 78.89 | 64.06 | 50.60 |
Key Financial Observations:
Profit After Tax (PAT):
PAT has shown a remarkable growth trajectory, surging from ₹1.80 Crores in FY24 to ₹7.75 Crores in FY25, a near 4x increase. This trend continues with ₹5.48 Crores profit in the first half of FY26, driven by improved operational efficiencies and better cost management.
Total Income:
Revenue has grown consistently at a healthy CAGR of 32% between FY23 and FY25, reaching ₹86.15 Crores in FY25. This growth reflects the company's success in capturing opportunities in the expanding Indian specialty chemicals market.
EBITDA:
Operational profit (EBITDA) has more than doubled from FY24 to FY25, with margins expanding significantly to over 15%. This indicates strong pricing power and efficiency in a volatile raw material environment.
Total Borrowings:
While absolute debt has increased to ₹38.54 Crores as of Sept 2025 to fund growth, the debt-to-equity ratio has improved significantly to 1.20x due to a faster increase in net worth. The IPO proceeds will further help in deleveraging.
Assets:
Total assets have nearly doubled in two years to ₹96.49 Crores, reflecting strategic investments in capacity and working capital to support the company's growth momentum.
P/E Ratio & Peer Comparison
Based on its Fiscal Year 2025 earnings per share (EPS) of ₹6.64, the IPO is priced at a Price-to-Earnings (P/E) multiple of approximately 14.8x at the upper end of the price band (₹98).
This valuation appears attractive when compared to its listed industry peers.
| Company Name | P/E Ratio | RoNW (%) (FY25) | ROCE (%) (FY25) | Net Profit Margin (%) |
Neochem Bio Solutions (at IPO price) | ~14.8x | 48.82% | 41.67% | 9.0% |
| Rossari Biotech Ltd | 26.00x | 12.21% | 16.19% | 6.6% |
| Indian Emulsifiers Ltd | 8.83x | 24.08% | 28.79% | 13.1% |
Analysis for Investors:
Neochem Bio is priced below the peer average P/E of roughly 17.4x.
More importantly, it boasts superior return ratios, with a Return on Net Worth (RoNW) of nearly 49% and ROCE of over 41%, significantly outperforming peers like Rossari Biotech.
This combination of a reasonable valuation and high efficiency makes it a compelling investment case.
Industry Outlook
Neochem Bio Solutions operates in the specialty chemicals sector, manufacturing customized formulations like polymers, surfactants, and silicones.
The Indian specialty chemicals industry is witnessing a structural upturn due to the "China Plus One" strategy and domestic demand growth.
Neochem caters to diverse industries, with a strong foothold in the textile sector.
The company's focus on R&D and sustainable bio-based solutions positions it well to capitalize on the industry's shift towards green chemistry.
What Are The Strengths and Risks of Neochem Bio Solutions IPO
Strengths:
- Impressive Financial Growth: A strong track record of revenue growth and a sharp jump in profitability margins.
- Superior Return Ratios: Best-in-class RoNW and ROCE indicate highly efficient use of capital.
- Established Track Record: Over 40 years of experience with a diverse product portfolio of over 350 formulations.
- Improving Balance Sheet: Significant reduction in the debt-to-equity ratio, which will improve further post-IPO.
Risks:
- Sectoral Concentration: A heavy reliance on the textile industry (over 77% of revenue) makes the company vulnerable to cyclical downturns in that sector.
- Geographic Concentration: Over 55% of revenue comes from Gujarat, exposing the company to regional risks.
- Negative Cash Flows: The company has reported negative cash flows from operations in recent periods, which is a key monitorable.
- Raw Material Volatility: Margins are sensitive to fluctuations in prices of chemical raw materials.
What Are the Expert Recommendations – Should You Apply?
Subscribe
The Neochem Bio Solutions IPO offers an opportunity to invest in a high-growth specialty chemicals company at a reasonable valuation.
- For Value Investors: The P/E of ~14.8x combined with exceptional return ratios makes this an attractive pick.
- For Growth Investors: The company's rapid profit growth and margin expansion indicate strong future potential.
- Our View: Despite the concentration risks and negative cash flow history, the company's strong fundamentals, long operating history, and attractive pricing make it a worthy investment.
Key Takeaways
- IPO Price Band: ₹93 to ₹98 per share
- Lot Size: 1,200 Shares (Minimum Investment: ₹1,17,600, as it falls under the retail category where the minimum application is usually around ₹1 lakh+). Correction: The minimum application amount is ₹1,11,600 at the lower band and ₹1,17,600 at the upper band.
- Allotment & Listing Dates: Tentative listing on December 9, 2025.
- Recommendations of experts: A "Subscribe" recommendation. A financially robust company with high efficiency ratios offered at a fair valuation.
FAQs on Neochem Bio Solutions IPO
What is Neochem Bio Solutions IPO price band?
The price band for the IPO is set at ₹93 to ₹98 per equity share.
What is Neochem Bio Solutions IPO allotment date?
The allotment of shares is tentatively expected to be finalized on Friday, December 5, 2025.
How to check Neochem Bio Solutions IPO allotment status?
You can check the allotment status on the website of the IPO registrar once the basis of allotment is finalized.
What is Neochem Bio Solutions IPO listing date?
The company's shares are tentatively scheduled to be listed on the NSE SME platform on Tuesday, December 9, 2025.
Should I apply for Neochem Bio Solutions IPO?
Yes, this is a recommended IPO. The company boasts superior financial efficiency compared to its peers and is offered at a reasonable valuation, making it an attractive investment opportunity despite its sectoral concentration.
Useful Links: Neochem Bio Solutions RHP
Disclaimer:
This content is for informational purposes only and does not constitute financial advice. Investing in an IPO carries risks. Please consult a qualified financial advisor before making any investment decisions.
